The UK HIV Drug Resistance Database was funded until 2020 by the UK Medical Research Council (grant 164587).
The study was originally funded by the Department of Health.
Additional funding has in the past been provided by:
- Tibotec, a division of Janssen-Cilag Limited
- Bristol-Myers Squibb Pharmaceuticals Limited
- Gilead Sciences Limited
- Public Health England